StockSelector.com
  Research, Select, & Monitor Saturday, April 21, 2018 3:17:50 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Juniper Pharmaceuticals, Inc.$9.05($.10)(1.09%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Juniper Pharmaceuticals, Inc. has an overall rank of 531 out of 6819 stocks based on 9 positive rankings and 5 negative rankings.

Positive Rankings
Top Intrinsic Values
Juniper Pharmaceuticals rank is 4
PEGValue
Juniper Pharmaceuticals has a PEG Value of $347.12. A stock is commonly considered to be fairly valued when its PE ratio equals its earnings growth rate. The PEG Value is the price where the PE Ratio, based on next year's earnings estimate, divided by the estimated growth rate over the next couple of years equals 1. This implies that if the company maintains its estimated growth rate, that the stock should gain 3,735.59% in the next year. Among companies with a PEG Value above the current stock price, Juniper Pharmaceuticals is ranked 13.
Up EPS Surprise
Juniper Pharmaceuticals beat the consensus earnings estimate when it last reported quarterly earnings.
Estimated Revenue Growth
Juniper Pharmaceuticals rank is 164
SSValue
The StockSelector Value for Juniper Pharmaceuticals is $53.64. The StockSelector Value assumes the market consistently prices a stock around a given PE ratio and, therefore, multiplies the average PE (using forward earnings estimates) over the past three years by future earnings estimates. Among companies with a StockSelector Value above the current stock price, Juniper Pharmaceuticals is ranked 252.
Historic Revenue Growth
Juniper Pharmaceuticals rank is 961
Debt-to-Equity
Juniper Pharmaceuticals rank is 971
Highest Cash Growth
Juniper Pharmaceuticals rank is 1065
Price-to-Sales
Juniper Pharmaceuticals rank is 2164
Negative Rankings
Negative Past Growth
Juniper Pharmaceuticals rank is 190
Negative Net Margin
Juniper Pharmaceuticals rank is 1212
Negative ROE
Juniper Pharmaceuticals rank is 1238
Negative ROA
Juniper Pharmaceuticals rank is 1334
Price-to-Book
Juniper Pharmaceuticals rank is 2049







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.